Cano Health Q2 EPS $(0.51) Misses $(0.12) Estimate, Sales $766.70M Miss $828.43M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cano Health (NYSE:CANO) reported Q2 losses of $(0.51) per share, missing the analyst consensus estimate of $(0.12) by 325 percent. This is a 1600 percent decrease from the same period last year. The company also reported quarterly sales of $766.70 million, missing the analyst consensus estimate of $828.43 million by 7.45 percent. However, this is an 11.22 percent increase from the same period last year.
August 10, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cano Health's Q2 earnings missed estimates significantly, with losses per share and sales both falling short of analyst consensus. This could negatively impact investor sentiment.
Cano Health's Q2 earnings were significantly below analyst estimates, with losses per share 325% greater than expected and sales missing estimates by 7.45%. This could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100